glp-1 gi obstruction lawsuit in west virginia The push to make weight-loss drugs more affordable is running into legal limits. Telehealth company Hims & Hers pulled a less expensive oral version of Wegovy after lawsuits from Novo Nordisk and Judge Allows New Ozempic, Wegovy

Legal Limbo: How the FDAs Decision Could Reshape the Weight Loss Drug Market The regulatory framework enabling Hims & Hers GLP-1 business rests on the FDAs drug shortage designations

Indigestion and burping Indigestion occurred in 9% of adults taking Wegovy, while burping occurred in 7% of adults and 4% of adolescents

Meal timing strategies affect side effect severity substantially

Microdosing semaglutide is gaining popularity as individuals seek benefits beyond weight loss

35 A phase IIb study (NATIVE) comparing lanifibranor with placebo in biopsy-proven NASH patients at 24 weeks of treatment demonstrated the efficacy in NASH resolution